These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 178842)

  • 41. Localization of Tc-99m-pyrophosphate in the liver due to massive liver necrosis: case report.
    Lyons KP; Kuperus J; Green HW
    J Nucl Med; 1977 Jun; 18(6):550-2. PubMed ID: 192858
    [No Abstract]   [Full Text] [Related]  

  • 42. Technetium-99m-labeled stannous imidodiphosphate, a new radiodiagnostic agent for bone scanning: comparison with other 99mTc complexes.
    Subramanian G; McAfee JG; Blair RJ; Rosenstreich M; Coco M; Duxbury CE
    J Nucl Med; 1975 Dec; 16(12):1137-43. PubMed ID: 1194964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Letter: Myocardial localization of 99mTc-pyrophosphate.
    Lentle BC; Jackson FI; Scott JR
    J Nucl Med; 1976 Sep; 17(9):852-3. PubMed ID: 182935
    [No Abstract]   [Full Text] [Related]  

  • 44. Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison.
    Rudd TG; Allen DR; Hartnett DE
    J Nucl Med; 1977 Sep; 18(9):872-6. PubMed ID: 197133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical comparison of the kinetics of 99mTc pyrophosphate and 99mTc methylene diphosphonate (author's transl)].
    Casara D; Cimitan M; Zorat P; Calzavara F
    Radiol Med; 1979; 65(1-2):67-70. PubMed ID: 223200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction.
    Zhao M; Zhu X; Ji S; Zhou J; Ozker KS; Fang W; Molthen RC; Hellman RS
    J Nucl Med; 2006 Aug; 47(8):1367-74. PubMed ID: 16883018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphologic correlates of technetium-99m stannous pyrophosphate imaging of acute myocardial infarcts in dogs.
    Buja LM; Parkey RW; Dees JH; Stokely EM; Harris RA; Bonte FJ; Willerson JT
    Circulation; 1975 Oct; 52(4):596-607. PubMed ID: 168990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms contributing to myocardial accumulation of technetium-99m stannous pyrophosphate after coronary arterial occlusion.
    Coleman RE; Klein MS; Ahmed SA; Weiss ES; Buchholz WM; Sobel BE
    Am J Cardiol; 1977 Jan; 39(1):55-9. PubMed ID: 188332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myocardial localization of 99mTc-pyrophosphate without evidence of acute myocardial infarction.
    Soin JS; Burdine JA; Beal W
    J Nucl Med; 1975 Oct; 16(10):944-6. PubMed ID: 170382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [99mTc-labeled sodium pyrophosphate in the study of primary and secondary bone cancer].
    Ducassou D; Leccia F; Pigneux J; Blanquet P
    Strahlentherapie Sonderb; 1975; 74():346-56. PubMed ID: 173050
    [No Abstract]   [Full Text] [Related]  

  • 51. Time-dependent image quality using 99mTc-pyrophosphate.
    Snow RM; Weber DA
    J Nucl Med; 1975 Oct; 16(10):879-82. PubMed ID: 170380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased localization of 99mTc-pyrophosphate in a bone island: case report.
    Sickles EA; Genant HK; Hoffer PB
    J Nucl Med; 1976 Feb; 17(02):113-5. PubMed ID: 173815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Editorial: Radioisotopic assessment of myocardial infarction.
    Myers RW; Goldstein RE
    N Engl J Med; 1974 Jul; 291(4):203-5. PubMed ID: 4834490
    [No Abstract]   [Full Text] [Related]  

  • 54. 99mTc pyrophosphate for diagnostic bone imaging.
    Weber DA; Keyes JW; Benedetto WJ; Wilson GA
    Radiology; 1974 Oct; 113(1):131-7. PubMed ID: 4370746
    [No Abstract]   [Full Text] [Related]  

  • 55. Cardiac localization of 99mTc-(Sn)-pyrophosphate following irradiation of the chest.
    Soin JS; Cox JD; Youker JE; Swartz HM
    Radiology; 1977 Jul; 124(1):165-8. PubMed ID: 194274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Letter: Use of stannotechnetiated (99mTc) pyrophosphate for the diagnosis of cerebrovascular accidents].
    Planiol T; Guillemart A; Besnard JC; Groussin P
    Nouv Presse Med; 1976 Mar; 5(12):793. PubMed ID: 177948
    [No Abstract]   [Full Text] [Related]  

  • 57. Localization of myocardial disorders other than infarction with 99mTc-labeled phosphate agents.
    Perez LA; Hayt DB; Freeman LM
    J Nucl Med; 1976 Apr; 17(4):241-6. PubMed ID: 176332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardioversion and "false positive" technetium-99m stannous pyrophosphate myocardial scintigrams.
    Pugh BR; Buja LM; Parkey RW; Poliner LR; Stokely EM; Bonte FJ; Willerson JT
    Circulation; 1976 Sep; 54(3):399-403. PubMed ID: 181172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myocardial infarct imaging with 99mTc-pyrophosphate and 99mTc-methylene diphosphonate: lack of correlation.
    Makler PT; Lederman S; Charkes ND; Malmud LS; Warner H; Reilley JJ
    Clin Nucl Med; 1979 Mar; 4(3):89-91. PubMed ID: 218770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.
    McRae J; Hambright P; Valk P; Bearden AJ
    J Nucl Med; 1976 Mar; 17(3):208-11. PubMed ID: 175138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.